News

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

Southlake, Texas, May 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the…

2 years ago

Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio

Newly issued US patent covers key step in the exosome manufacturing processOXFORD, United Kingdom, May 17, 2023 (GLOBE NEWSWIRE) --…

2 years ago

Trina Lally Joins PetVivo Holdings, Inc. as the Northeast Business Development Manager

PetVivo Holdings, Inc. Trina Lally MINNEAPOLIS, MN, US, May 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV &…

2 years ago

Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer

Media Release Immuno-oncology combination of eftilagimod alpha (efti) and the leading anti-PD-1 therapy generates meaningful long-term survival in non-small cell…

2 years ago

Sensus Healthcare’s SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet Patients

BOCA RATON, Fla, May 17, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare Inc. (Nasdaq:SRTS), the leading manufacturer of advanced medical devices…

2 years ago

Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank

Refinanced Loan Extends Maturity to December 2024SEATTLE and VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences,…

2 years ago

Mendus secures third shareholder loan from Van Herk Investments

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company has…

2 years ago

Ultragenyx Receives FDA Agreement to Expand Ongoing Global Phase 1/2 Trial Evaluating GTX-102 in Patients with Angelman Syndrome in the U.S.

Amended U.S. protocol increases loading and maintenance doses to similar range as ex-U.S. expansion cohortsNOVATO, Calif., May 17, 2023 (GLOBE…

2 years ago

IntelGenx Receives Amended DEL License to Conduct Third-Party Testing

- Provides opportunity to address market gap, catering to growing industry demand for reliable and efficient testing services - SAINT…

2 years ago

IN8bio’s DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer

Preclinical results showcase the potential for the strong synergistic combination of chemotherapy and gamma-delta T cell therapy to target solid…

2 years ago